Edwards Lifesciences Corp Quarterly Common Stock, Shares, Issued from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Edwards Lifesciences Corp quarterly Common Stock, Shares, Issued history and growth rate from Q2 2010 to Q2 2024.
  • Edwards Lifesciences Corp Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 654M shares, a 0.68% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 654M +4.4M +0.68% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 652M +4.7M +0.73% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 651M +4.2M +0.65% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 650M +4.2M +0.65% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 649M +4.1M +0.64% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 647M +4.2M +0.65% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 646M +4.3M +0.67% Dec 31, 2022 10-K 2024-02-12
Q3 2022 646M +4.5M +0.7% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 645M +4.9M +0.77% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 643M +5.4M +0.85% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 642M +5.6M +0.88% Dec 31, 2021 10-K 2023-02-13
Q3 2021 641M +6.2M +0.98% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 640M +6.6M +1.04% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 638M +419M +192% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 636M +418M +192% Dec 31, 2020 10-K 2022-02-14
Q3 2020 635M +418M +192% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 634M +417M +192% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 219M +2.5M +1.16% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 218M +2.9M +1.35% Dec 31, 2019 10-K 2021-02-12
Q3 2019 218M +2.7M +1.26% Sep 30, 2019 10-Q 2019-10-25
Q2 2019 217M +2.9M +1.36% Jun 30, 2019 10-Q 2019-07-26
Q1 2019 216M +3M +1.41% Mar 31, 2019 10-Q 2019-04-26
Q4 2018 215M +3.2M +1.51% Dec 31, 2018 10-K 2020-02-14
Q3 2018 215M +3.2M +1.51% Sep 30, 2018 10-Q 2018-10-26
Q2 2018 214M -30.7M -12.5% Jun 30, 2018 10-Q 2018-07-27
Q1 2018 213M -30.2M -12.4% Mar 31, 2018 10-Q 2018-04-27
Q4 2017 212M -30.6M -12.6% Dec 31, 2017 10-K 2019-02-15
Q3 2017 212M -30.4M -12.6% Sep 30, 2017 10-Q 2017-10-27
Q2 2017 245M +3.7M +1.54% Jun 30, 2017 10-Q 2017-07-28
Q1 2017 243M +3.4M +1.42% Mar 31, 2017 10-Q 2017-04-28
Q4 2016 243M +3.5M +1.46% Dec 31, 2016 10-K 2018-02-16
Q3 2016 242M +112M +85.9% Sep 30, 2016 10-Q 2016-10-28
Q2 2016 241M +111M +85.5% Jun 30, 2016 10-Q 2016-07-29
Q1 2016 240M +110M +85.3% Mar 31, 2016 10-Q 2016-04-29
Q4 2015 239M +110M +85.5% Dec 31, 2015 10-K 2017-02-17
Q3 2015 130M +2.2M +1.72% Sep 30, 2015 10-Q 2015-10-29
Q2 2015 130M +2.8M +2.2% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 129M +3M +2.37% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 129M +2.9M +2.3% Dec 31, 2014 10-K 2016-02-19
Q3 2014 128M +2.3M +1.83% Sep 30, 2014 10-Q 2014-10-31
Q2 2014 127M +1.7M +1.36% Jun 30, 2014 10-Q 2014-08-04
Q1 2014 126M +1.7M +1.36% Mar 31, 2014 10-Q 2014-05-02
Q4 2013 126M +1.8M +1.45% Dec 31, 2013 10-K 2015-02-20
Q3 2013 126M +1.8M +1.45% Sep 30, 2013 10-Q 2013-11-07
Q2 2013 125M +2.4M +1.95% Jun 30, 2013 10-Q 2013-08-06
Q1 2013 125M +3.6M +2.97% Mar 31, 2013 10-Q 2013-05-06
Q4 2012 124M +4.2M +3.5% Dec 31, 2012 10-K 2014-02-28
Q3 2012 124M +4.4M +3.68% Sep 30, 2012 10-Q 2012-11-07
Q2 2012 123M +4.2M +3.54% Jun 30, 2012 10-Q 2012-08-07
Q1 2012 121M +3.4M +2.89% Mar 31, 2012 10-Q 2012-05-09
Q4 2011 120M +3M +2.56% Dec 31, 2011 10-K 2013-02-28
Q3 2011 120M +3.4M +2.93% Sep 30, 2011 10-Q 2011-11-08
Q2 2011 119M +3.7M +3.22% Jun 30, 2011 10-Q 2011-08-08
Q1 2011 118M Mar 31, 2011 10-Q 2011-05-09
Q4 2010 117M Dec 31, 2010 10-K 2012-02-27
Q3 2010 116M Sep 30, 2010 10-Q 2010-11-08
Q2 2010 115M Jun 30, 2010 10-Q 2010-08-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.